NEPHROS INC (NEPH) Insider Trading Disclosures
NEPHROS INC (NEPH) is a publicly traded company on the Nasdaq, categorized under SIC 3841 (Surgical & Medical Instruments & Apparatus). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: NEPH
CIK: 1196298
Exchange: Nasdaq
SIC 3841: Surgical & Medical Instruments & Apparatus
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Baker Tilly US, LLP
Auditor SinceSince 12/31/2021 12:00:00 AM
Lead Engagement PartnerKristen Godsoe
Audit LocationTewksbury, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| DEF 14A | 2026-10-14 | 2026-10-14 | DEF 14A | 0001493152-26-047012 | View SEC Doc Filr Page |
| 8-K | 2026-10-13 | 2026-10-13 | 8-K | 0001493152-26-046814 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-09-16 | — | SCHEDULE 13D/A Filing | 0001398344-26-017130 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-09-16 | — | SCHEDULE 13G Filing | 0001398344-26-017126 | View SEC Doc Filr Page |
| 4 | 2026-09-16 | 2026-09-14 | 4 Filing | 0001398344-26-017120 | View SEC Doc Filr Page |
| 4 | 2026-09-16 | 2026-09-14 | 4 Filing | 0001398344-26-017116 | View SEC Doc Filr Page |
| 4 | 2026-08-20 | 2026-08-18 | 4 Filing | 0001398344-26-015086 | View SEC Doc Filr Page |
| 4 | 2026-08-14 | 2026-08-12 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0000914190-26-000110 | View SEC Doc Filr Page |
| 10-Q | 2026-08-10 | 2026-06-30 | 10-Q | 0001493152-26-036851 | View SEC Doc Filr Page |
| 8-K | 2026-08-06 | 2026-08-06 | 8-K | 0001493152-26-036331 | View SEC Doc Filr Page |
| 8-K | 2026-06-15 | 2026-06-12 | 8-K | 0001493152-26-028539 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-05-11 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0000914190-26-000098 | View SEC Doc Filr Page |
| 8-K | 2026-05-07 | 2026-05-07 | 8-K | 0001493152-26-021734 | View SEC Doc Filr Page |
| 10-Q | 2026-05-07 | 2026-03-31 | 10-Q | 0001493152-26-021701 | View SEC Doc Filr Page |
| 10-K/A | 2026-04-30 | 2025-12-31 | 10-K/A | 0001493152-26-020416 | View SEC Doc Filr Page |
| 8-K | 2026-03-27 | 2026-03-27 | 8-K | 0001493152-26-013189 | View SEC Doc Filr Page |
| 4 | 2026-03-25 | 2026-03-23 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0000914190-26-000053 | View SEC Doc Filr Page |
| 4 | 2026-03-25 | 2026-03-23 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0000914190-26-000052 | View SEC Doc Filr Page |
| 4 | 2026-03-18 | 2026-03-16 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0000914190-26-000042 | View SEC Doc Filr Page |
| 4 | 2026-03-18 | 2026-03-16 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0000914190-26-000041 | View SEC Doc Filr Page |
| 10-K | 2026-03-12 | 2025-12-31 | 10-K | 0001493152-26-009848 | View SEC Doc Filr Page |
| 8-K | 2025-11-26 | 2025-11-21 | 8-K | 0001493152-25-025155 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2025-11-14 | — | SCHEDULE 13G Filing | 0001193125-25-281315 | View SEC Doc Filr Page |
| 4 | 2025-11-13 | 2025-11-10 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0000914190-25-000041 | View SEC Doc Filr Page |
| 4 | 2025-11-13 | 2025-11-10 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0000914190-25-000040 | View SEC Doc Filr Page |